Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,514 Cr
up ₹205 Cr vs May 2026
- Stocks held
- 28
- unchanged
- Top 10 weight
- 64.0%
- of the portfolio in its ten largest
- Cash & debt
- 6.8%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 8
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In June 2026 it disclosed 28 stocks worth ₹3,514 Cr, up ₹205 Cr from May 2026. Its largest positions were Cipla Limited (8.3%), IPCA Laboratories Limited (8.2%), Sun Pharmaceutical Industries Limited (8.1%); the ten largest together made up 64.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 61.5% of its equity. Cash and debt stood at 6.8%. Compared with May 2026 the fund entered 1 new stock and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
84%
Holds more cash than 84% of peers
What these mean: concentration · cash
Holdings in June 2026
Download CSVEvery line the fund disclosed, with the change against May 2026. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Cipla Limited | 8.35% | up 0.67 pts | ₹293 Cr | up ₹39.2 Cr | Added |
| IPCA Laboratories Limited | 8.21% | up 0.40 pts | ₹289 Cr | up ₹30 Cr | Added |
| Sun Pharmaceutical Industries Limited | 8.14% | down 0.21 pts | ₹286 Cr | up ₹9.7 Cr | Added |
| Illumina Inc | 7.59% | up 0.06 pts | ₹267 Cr | up ₹17.5 Cr | Added |
| Sai Life Sciences Limited | 6.88% | up 0.01 pts | ₹242 Cr | up ₹14.5 Cr | Added |
| Cash, TREPS & receivables | 6.78% | up 0.43 pts | ₹238 Cr | up ₹28.2 Cr | Added |
| Gland Pharma Limited | 6.54% | up 0.28 pts | ₹230 Cr | up ₹22.6 Cr | Added |
| Globus Medical Inc | 5.72% | down 0.63 pts | ₹201 Cr | down ₹9 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 4.81% | down <0.01 pts | ₹169 Cr | up ₹9.8 Cr | Added |
| Suven Pharmaceuticals Limited | 4.13% | down 0.02 pts | ₹145 Cr | up ₹7.8 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.60% | down 0.10 pts | ₹127 Cr | up ₹4.1 Cr | Added |
| Alembic Pharmaceuticals Limited | 3.38% | up 0.17 pts | ₹119 Cr | up ₹12.5 Cr | Added |
| Kovai Medical Center and Hospital Limited | 2.87% | up 0.19 pts | ₹101 Cr | up ₹12.2 Cr | Added |
| Procter & Gamble Health Limited | 2.87% | down 0.05 pts | ₹101 Cr | up ₹4.3 Cr | Added |
| Alkem Laboratories Limited | 2.61% | up 1.99 pts | ₹91.8 Cr | up ₹71.3 Cr | Added |
| Pfizer Limited | 2.53% | down 0.25 pts | ₹89.1 Cr | down ₹3.2 Cr | Trimmed |
| Indoco Remedies Limited | 2.21% | up 0.15 pts | ₹77.6 Cr | up ₹9.6 Cr | Added |
| Intuitive Surgical Inc | 2.01% | down 0.29 pts | ₹70.6 Cr | down ₹5.4 Cr | Trimmed |
| Concord Biotech Limited | 1.81% | up 0.23 pts | ₹63.6 Cr | up ₹11.4 Cr | Added |
| Unichem Laboratories Limited | 1.46% | up 0.56 pts | ₹51.3 Cr | up ₹21.4 Cr | Added |
| Syngene International Limited | 1.38% | up 1.38 pts | ₹48.7 Cr | up ₹48.7 Cr | New |
| Nephrocare Health Services Ltd | 1.22% | up 0.08 pts | ₹43 Cr | up ₹5 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 1.20% | down 0.11 pts | ₹42 Cr | down ₹1.2 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.94% | up 0.06 pts | ₹32.9 Cr | up ₹3.9 Cr | Added |
| Aarti Drugs Limited | 0.92% | down 0.06 pts | ₹32.2 Cr | down ₹21 L | Trimmed |
| Abbott Laboratories | 0.77% | down 0.01 pts | ₹27.1 Cr | up ₹1.3 Cr | Added |
| Jupiter Life Line Hospitals Limited | 0.38% | up <0.01 pts | ₹13.4 Cr | up ₹88 L | Added |
| Emcure Pharmaceuticals Limited | 0.37% | down 1.14 pts | ₹12.8 Cr | down ₹37 Cr | Trimmed |
| Laxmi Dental Limited | 0.18% | down 0.02 pts | ₹6.3 Cr | down ₹21 L | Trimmed |
| Grail Inc | 0.16% | down 0.02 pts | ₹5.6 Cr | down ₹33 L | Trimmed |
What changed, May 2026 to Jun 2026
New New positions (1)
- Syngene International Limited1.4% · ₹48.7 Cr
Exited Exited (1)
- Laurus Labs Limitedwas 3.8% · ₹125 Cr
Added Biggest additions
- Alkem Laboratories Limitedup ₹71.3 Cr (+1.99% pts)
- Cipla Limitedup ₹39.2 Cr (+0.67% pts)
- IPCA Laboratories Limitedup ₹30 Cr (+0.40% pts)
- Gland Pharma Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2026, the weight rose most in Healthcare Services (+1.8 pts) and Pharmaceuticals (+0.8 pts), and fell most in Pharmaceuticals & Biotechnology (−1.6 pts) and Healthcare Equipment & Supplies (−1.0 pts).
- Healthcare Services22.0% → 23.9%+1.8 pts
- Pharmaceuticals4.0% → 4.8%+0.8 pts
- Pharmaceuticals & Biotechnology63.0% → 61.5%−1.6 pts
- Healthcare Equipment & Supplies9.5% → 8.6%−1.0 pts
- Insurance1.4% → 1.3%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2023 | Jun 2025 | Dec 2025 | Mar 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.1% | 67.0% | 64.1% | 64.0% | 63.0% | 61.5% |
| Healthcare Services | 13.6% | 16.7% | 18.7% | 19.3% | 22.0% | 23.9% |
| Healthcare Equipment & Supplies | 6.4% | 7.8% | 10.3% | 10.8% | 9.5% | 8.6% |
| Pharmaceuticals | 5.4% | 6.3% | 4.9% | 3.9% | 4.0% | 4.8% |
| Insurance | 2.4% | 1.6% | 1.5% | 1.5% | 1.4% | 1.3% |
Allocation in Jun 2026change vs May 2026
- Pharmaceuticals & Biotechnology (13)61.5%▼ 1.6 pts
- Healthcare Services (8)23.9%▲ 1.8 pts
- Healthcare Equipment & Supplies (3)8.6%▼ 1.0 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2026
6.8%
▲ 0.4 pts vs May 2026
- Cash alone
- 6.8%
- cash and net receivables
- A year earlier
- 1.1%
- Jun 2025 · now ▲ 5.7 pts
- Last 12 months
- 1.0% – 6.8%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.